Evaluation of the Tantalus System in Type 2 Diabetic Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

June 30, 2007

Conditions
Type 2 DiabetesObesity
Interventions
DEVICE

Implantable pulse generator and electrodes

Trial Locations (1)

1090

Allgemeinen Krankenhauses der Stadt Wein AkH, Vienna

All Listed Sponsors
lead

MetaCure Limited

INDUSTRY

NCT00276471 - Evaluation of the Tantalus System in Type 2 Diabetic Subjects | Biotech Hunter | Biotech Hunter